Friday, September 20, 2024
HomeIndustriesHealthcare

Healthcare

Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses

Johnson & Johnson (the Company) announced preliminary results from an independent study, including a subset of participants from the Janssen-sponsored COV2008 study, conducted by...

GreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidate

GreenLight Biosciences (ENVI) and IAVI, a nonprofit scientific research organization, today announced work on a messenger RNA vaccine candidate to tackle the COVID-19 Omicron...

Discovery Life Sciences acquires In Vitro ADMET Laboratories

Discovery Life Sciences  (Discovery), the biospecimen and biomarker specialists™,  announced that it has acquired In Vitro ADMET Laboratories (IVAL) to add the world's largest...

Ketamine Wellness Centers (KWC) Announces Plans to Expand Operations into Salt Lake City and Reno

Delic Holdings Corp, a leader in new medicines and treatments for a modern world, today announced its subsidiary Ketamine Wellness Centers (KWC) plans to...

RemeGen’s Telitacicept and Disitamab Vedotin Enter China’s National Reimbursement Drug List for SLE and Gastric Cancer Treatment

RemeGen Co., Ltd., a commercial-ready biotechnology company, announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic...
0FansLike
0FollowersFollow
spot_img

Hot Topics